Insulin aspart, recombinant Subcutaneous and Methyldopa Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Methyldopa Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: methyldopa
Brand name: Aldomet
Synonyms: Methyldopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Methyldopate
- Insulin aspart, recombinant Subcutaneous-Methyldopate hydrochloride
- Insulin aspart, recombinant Subcutaneous-Methylene Blue
- Insulin aspart, recombinant Subcutaneous-Methylene blue injection
- Insulin aspart, recombinant Subcutaneous-Methylene blue Oral, Intravenous
- Insulin aspart, recombinant Subcutaneous-Methylergonovine
- Methyldopa Tablets-Insulin degludec
- Methyldopa Tablets-Insulin Degludec (U-100) Prefilled Pens
- Methyldopa Tablets-Insulin Degludec (U-100) Vials
- Methyldopa Tablets-Insulin Degludec (U-200) Prefilled Pens
- Methyldopa Tablets-Insulin degludec and liraglutide
- Methyldopa Tablets-Insulin degludec and liraglutide Subcutaneous